Abstract
In respect to the classification of thyroid cancer, there are different scoring systems in use which are based on multivariate analyses. However, traditional TNM classification of the American Joint Commission on Cancer (AJCC) and the International Union Against Cancer (UICC) is the most commonly and widely accepted. The AJCC/UICC TNM classification is regularly revised by a panel of thyroid cancer experts. The major alterations of the 5th edition (1997) as compared to the 6th (2002/2003) and the current 7th (2009) edition refer to microcarcinomas, tumours with extrathyroidal extension and lymph node metastases. The rationale and the impact of the changes on scientific research and clinical decision making are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bellantone R, Lombardi CP, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M, Crucitti F (1998) Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 68:237–241
Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M (1979) A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033–1041
DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon
Dietlein M, Dressler J, Eschner W, Grünwald F, Lassmann M, Leisner B, Luster M, Moser E, Reiners C, Schicha H, Schober O; Deutsche Gesellschaft für Nuklearmedizin; Deutsche Gesellschaft für Medizinische Physik (2007) Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3). Nuklearmedizin 46:213–219
Dralle H, Scheumann GFW, Kotzerke J, Brabant E (1992) Surgical management of MEN 2. Recent Results Cancer Res 125:167–195
Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL (1996) Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 9:816–820
Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH (2004) The process for continuous improvement of the TNM classification. Cancer 100:1–5
Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Hughes CJ, Shaha AR, Shah JP, Loree TR (1996) Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18:127–132
Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006a) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786
Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006b) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36:12–18
Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848
Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G (2004) Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11:571–579
Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 6:469–476
Piersanti M, Ezzat S, Asa SL (2003) Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 14:183–191
Rahbar K, Hutzenlaub V, Fischer RJ, Schober O, Riemann B (2008) Risk-profile and outcome of small papillary and follicular thyroid carcinomas. Nuklearmedizin 47:188–194
Riemann B, Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Sauerland C, Frankewitsch T, Schober O for the MSDS study group (2010) Risk stratification of patients with locally aggressive differentiated thyroid cancer: results of the MSDS trial. Nuklearmedizin 49:79–84
Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW (1991) Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117:601–605
Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251
Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–567
Schmid KW, Wittekind C (2003) Die missglückte Klassifikation. Pathologe 24:338
Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR 3rd (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012–1021
Sobin LH, Wittekind C (1997) UICC TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York
Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New York
Verburg FA, Mäder U, Kruitwagen CL, Luster M, Reiners C (2010) A comparison of prognostic classification systems for differentiated thyroid carcinoma. Clin Endocrinol 72:830–838
Verburg FA, Stokkel MP, Düren C, Verkooijen RB, Mäder U, van Isselt JW, Marlowe RJ, Smit JW, Reiners C, Luster M (2010) No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 37:276–283
Voutilainen PE, Siironen P, Franssila KO, Sivula A, Haapiainen RK, Haglund CH (2003) AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 23:4283–4288
Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM Supplement. A Commentary on Uniform Use, 3rd edn. Wiley-Liss, New York
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schober, O., Riemann, B. (2012). UICC Classifications 1997, 2002 and 2009: What is the Impact on Thyroid Cancer Mangement?. In: Baum, R. (eds) Therapeutic Nuclear Medicine. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2012_745
Download citation
DOI: https://doi.org/10.1007/174_2012_745
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36718-5
Online ISBN: 978-3-540-36719-2
eBook Packages: MedicineMedicine (R0)